शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans

This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →

KRONOXBSEKRONOX LAB SCIENCES LTD· Chemicals & PetrochemicalsHighNeutral
Announced Thu, 5 Nov, 2026 · 14:07 IST

Standalone Sep 2026 quarter: revenue up 5.1% year on year; EBITDA margin narrows; results approved

Emphasis of matterEBITDA margin compressionResults restatedRevenue growth above 20%Profit growth above 25%Results View source PDFExplain this filing

KRONOX · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.0%Reaction day
₹198.00
prior close
₹199.10
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.1%-2.1% vs market
Specialty Chemicals peers, median of 100sector+0.7%-1.7% vs sector

On the reaction day the stock moved 2.1 pts less than Nifty Microcap 250 and 1.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
-2.6
15m
-2.6
30m
-1.6
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.0+1.1-2.1+0.7-1.7
Next day
-4.0pendingpending+0.0-4.0
2d
—————
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 100Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Standalone quarter ended Sep 30, 2026: revenue rose 5.1% year on year to Rs 2,683.42 lakh and profit after tax fell 3.5% to Rs 644.03 lakh. EBITDA margin narrowed to 31.4%. Standalone half-year: revenue Rs 5,522.06 lakh, net profit Rs 1,374.33 lakh, operating cash flow Rs 1,604.13 lakh. Indo Borax took 64.26% control on Sep 29; auditor flagged the board and management change but raised no objection. Prior figures were regrouped or reclassified.

Likely market impact

Lower profit and a narrower margin may weigh on the stock, while strong cash flow and Indo Borax's control may support it.

By the numbersStandalone · Q2 FY27 vs Q2 FY26
Q2 FY27Q2 FY26Change
Revenue₹55.22 Cr₹25.53 Cr+116.3%
Operating profit₹16.38 Cr₹8.14 Cr+101.3%
Profit after tax₹13.74 Cr₹6.68 Cr+105.9%
EBITDA margin31.6%33.9%−2.3 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.